NEW YORK (GenomeWeb News) – Autoimmune molecular diagnostics firm Ignyta said this week that it has raised $5.5 million in an expanded Series B equity financing round.

Additionally, the firm received a $500,000 capital term loan in June 2012 from Silicon Valley Bank bringing the total in Series B-related proceeds to $6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.